DogtorRx has been clinically tested and approved by veterinarians across the USA. In 2005, Dr. Ava V. Ackerman, DVM, at Belmont Pet Hospital in Belmont, CA, conducted the first study evaluating the safety and effectiveness of our standardized oligopeptide formula.
The study focused on aging dogs with orthopedic issues and those with suspected or diagnosed Cushing’s Disease. The results were remarkable, showing significant improvements in dogs suffering from Cushing’s Disease, osteoarthritis, dysplasia, and inflammatory joint disease – with no adverse effects reported.
DogtorRx continues to provide trusted solutions for healthier, happier pets.
